Cutera, Inc. (NASDAQ:CUTR) Short Interest Update

Cutera, Inc. (NASDAQ:CUTR) saw a large drop in short interest in December. As of December 15th, there was short interest totalling 4,080,000 shares, a drop of 7.3% from the November 30th total of 4,400,000 shares. Based on an average trading volume of 292,300 shares, the days-to-cover ratio is presently 14.0 days.

Cutera Stock Performance

CUTR opened at $0.33 on Monday. Cutera has a 52-week low of $0.28 and a 52-week high of $4.97. The company’s 50-day simple moving average is $0.44 and its two-hundred day simple moving average is $0.84. The stock has a market capitalization of $6.62 million, a P/E ratio of -0.05 and a beta of 1.26.

Institutional Trading of Cutera

A number of hedge funds have recently bought and sold shares of CUTR. Ground Swell Capital LLC purchased a new position in Cutera in the second quarter worth about $37,000. Squarepoint Ops LLC lifted its stake in shares of Cutera by 164.5% in the 2nd quarter. Squarepoint Ops LLC now owns 113,964 shares of the medical device company’s stock worth $172,000 after purchasing an additional 70,870 shares during the period. Finally, Bank of Montreal Can boosted its holdings in shares of Cutera by 14.2% in the second quarter. Bank of Montreal Can now owns 282,704 shares of the medical device company’s stock worth $455,000 after buying an additional 35,248 shares during the last quarter. Hedge funds and other institutional investors own 90.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on Cutera in a research report on Saturday. They set a “sell” rating for the company.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.